The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic impact of TERT
promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 2, Pages 414-423
Publisher
Wiley
Online
2016-02-26
DOI
10.1002/ijc.30057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation
- (2015) Dong-Sheng Huang et al. EUROPEAN JOURNAL OF CANCER
- KIAA1549
- (2015) Aline Paixão Becker et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
- (2015) Sabine Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
- (2015) Ke Gao et al. Oncotarget
- TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
- (2015) Mohamed Ali Mosrati et al. Oncotarget
- TERT promoter mutations and telomere length in adult malignant gliomas and recurrences
- (2015) Barbara Heidenreich et al. Oncotarget
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
- (2015) Patrick J. Killela et al. Oncotarget
- Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma
- (2015) Chul-Kee Park et al. Oncotarget
- TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
- (2014) M Labussière et al. BRITISH JOURNAL OF CANCER
- Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)
- (2014) Nathália C Campanella et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas
- (2014) Miguel Melo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas
- (2014) Matthias Simon et al. NEURO-ONCOLOGY
- Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
- (2014) M. Labussiere et al. NEUROLOGY
- TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
- (2014) Chen Chen et al. PLoS One
- TERT promoter mutations in primary and secondary glioblastomas
- (2013) Naosuke Nonoguchi et al. ACTA NEUROPATHOLOGICA
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Highly prevalentTERTpromoter mutations in bladder cancer and glioblastoma
- (2013) Xiaoli Liu et al. CELL CYCLE
- Highly prevalent TERT promoter mutations in aggressive thyroid cancers
- (2013) Xiaoli Liu et al. ENDOCRINE-RELATED CANCER
- TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
- (2013) P. S. Rachakonda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Paediatric and adult malignant glioma: close relatives or distant cousins?
- (2012) Chris Jones et al. Nature Reviews Clinical Oncology
- Alternative lengthening of telomeres: models, mechanisms and implications
- (2010) Anthony J. Cesare et al. NATURE REVIEWS GENETICS
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
- (2009) D T W Jones et al. ONCOGENE
- Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas
- (2008) David T.W. Jones et al. CANCER RESEARCH
- Understanding and exploitinghTERTpromoter regulation for diagnosis and treatment of human cancers
- (2008) Satoru Kyo et al. CANCER SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now